LUCIA CABANELA MACIAS: Open Payments
NPI 1992552095 · FORT PIERCE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$826 in 34 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $284 · 2025 $826
Food & beverage: $826
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $351 |
| Otsuka America Pharmaceutical, Inc. | 3 | $164 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $138 |
| Janssen Pharmaceuticals, Inc | 2 | $47 |
| Axsome Therapeutics, Inc. | 2 | $38 |
| Janssen Scientific Affairs, LLC | 1 | $32 |
| Lundbeck LLC | 1 | $20 |
| Alkermes, Inc. | 1 | $20 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
Products named: VRAYLAR, REXULTI, CAPLYTA, SPRAVATO, Auvelity, VIVITROL, Qelbree.
Industry payments across FL — which companies pay providers there.
